The Greatest Opportunities to Enhance Drug Development in 2025

greatest-opportunities-enhance-drug-development-2025

The pharma industry continues to persevere through talent shortages, supply chain disruptions, data challenges, and many more obstacles that are making it increasingly difficult to get life-saving treatments to patients. However, the thirst for innovation and drive to make a difference for patients around the world is what keeps this sector going. As we start […]

Unlocking Value Potential for a Client’s Rare Disease Treatment

unlocking-value-potential-clients-rare-disease-treatment

A pharmaceutical manufacturer faced challenges in identifying patients early in the treatment journey for a rare disease, aiming to improve its medication uptake. The client was aiming to: Identify new revenue opportunities by uncovering untreated patient populations Tackle healthcare access disparities affecting underserved groups Optimize provider engagement and reimbursement strategies

Innovation Trends from R&D to Market Access

Innovation-trends-rd-market-access

2024 has been an incredibly busy year for Norstella as its constituent organizations – Citeline, Evaluate, MMIT, Panalgo, and the Dedham Group – have continued to support the biopharma ecosystem in bringing new therapies to patients. Throughout the course of the year, we have also shared our latest views on the issues that are most […]

Assessing AI Transformation in Pharma R&D: Current and Future Impact

current-future-impact-AI-pharmaceutical-RD

Artificial intelligence (AI) has been one of the largest disruptors in drug development over the past few years, with the promise of innovation and greater efficiencies keeping the pharma industry heavily invested. There have been major advancements in AI-discovered molecules and AI-powered platforms for decentralized treatment, in addition to many more AI applications that have […]

Level Up Your Lab Data: New Use Cases for Improving Time to Treatment

Level-Up-Your-Lab-Data-Improving-Time-Treatment

This webinar explores how integrated laboratory and real-world data (RWD) are helping accelerate diagnosis, patient identification, clinical trial recruitment, and commercialization. Norstella and Quest Diagnostics highlight how linked claims, lab, EMR, and unstructured data support precision medicine, physician targeting, and earlier disease detection across oncology, neurology, rare disease, and autoimmune conditions. The discussion also covers […]

The Current & Future Impact of AI on Pharmaceutical R&D

current-future-impact-AI-pharmaceutical-RD

Artificial intelligence (AI) continues to disrupt existing paradigms in drug development, with early adopters experiencing both the benefits and challenges of this innovative technology. With that in mind, Norstella surveyed 125 senior decision-makers in the life sciences industry on their perceptions and expectations of AI to understand current AI adoption trends in addition to the […]

Redefining Patient Access Strategy

patient-access-strategy

Patient access continues to be a major hurdle in the US pharma industry, impacting the speed of drug development and therefore the delivery of life-saving treatments to patients. To assess the current state of patient access, Norstella’s Managed Markets Insight & Technology (MMIT) surveyed over 300 industry professionals on major trends and challenges in pharma […]

The Next Wave in Oncology: 7 Innovations Redefining Cancer Treatment in 2024 and Beyond

next-wave-oncology

Oncology is undergoing a transformative shift, with new therapies and technologies driving significant improvements in cancer care. The Next Wave in Oncology explores seven groundbreaking advancements, from antibody-drug conjugates (ADCs) to artificial intelligence, that are redefining how cancer is treated. Staying up to date on these innovations is essential for those navigating the rapidly changing […]

How Norstella is Embedding Artificial Intelligence to Improve Pipeline to Patient Decision-Making

norstella-embedding-ai

In this white paper, Norstella describes its vision for the integration of artificial intelligence with its industry-leading data and advisory services. At each step from pipeline to patient, Norstella is embedding AI to create the next generation of solutions. These will help biopharma professionals to better contextualize their challenges, predict how scenarios will play out, […]

Norstella Brands